{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/blepharitis/management/management-of-blepharitis/","result":{"pageContext":{"chapter":{"id":"a41dab9c-d988-5d7a-813e-2d7a1658f5bc","slug":"management-of-blepharitis","fullItemName":"Scenario: Management of blepharitis","depth":2,"htmlHeader":"<!-- begin field 43902d37-5163-4d8c-9d88-17b6d7025e5a --><h2>Scenario: Management of blepharitis</h2><!-- end field 43902d37-5163-4d8c-9d88-17b6d7025e5a -->","summary":"Covers the management of chronic blepharitis, including when to refer a person with blepharitis.","htmlStringContent":"<!-- begin item 062afb95-54f7-4878-b838-2fcf5a69a523 --><!-- begin field 4e64055d-1872-4f62-bc87-acbd008527ed --><p>From age 12 years onwards.</p><!-- end field 4e64055d-1872-4f62-bc87-acbd008527ed --><!-- end item 062afb95-54f7-4878-b838-2fcf5a69a523 -->","topic":{"id":"210e4b01-890a-5a0a-a3cf-efcece1eb08e","topicId":"1bba37b4-ec1b-49d5-acc1-6fc1671711cf","topicName":"Blepharitis","slug":"blepharitis","lastRevised":"Last revised in April 2019","chapters":[{"id":"b93c0a0c-4692-53c9-843f-49ee05545451","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9c38019b-31fa-5b39-9bb8-b27769998a9b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9620e929-162c-539c-b063-b0d2d792fc78","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fd79cb69-88c9-53b3-a6a8-4bc9d0b0848f","slug":"changes","fullItemName":"Changes"},{"id":"ccbb8929-8463-57af-b3d5-cf785a546c74","slug":"update","fullItemName":"Update"}]},{"id":"4111c3c7-ee03-523b-800b-280e6b45dfbf","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"aff6bd9c-9a5d-5a90-9983-0fb81983feba","slug":"goals","fullItemName":"Goals"},{"id":"ec8eea31-e7ad-50f8-a443-eb9120f2bd11","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7d5547f8-0c93-5d41-9cd4-d98e71ef7975","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4e0b92f2-dd2a-568f-9ce8-bfcc52e4599d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"960b987f-d9f7-5a39-8b20-715ba8988e6b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"250fbd5e-7fdf-5849-bf02-a9c794a764ef","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"44811d5c-7af7-54f4-8fbe-e23a28523234","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"09fc8800-1ae4-546d-be0b-62e044edfca1","slug":"definition","fullItemName":"Definition"},{"id":"6899ed96-f696-5938-9656-d097419cff77","slug":"causes","fullItemName":"Causes"},{"id":"9a08c813-358a-52ed-8317-6734ad0caa2c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9261cec2-b5d4-5c5d-9e32-4a0d9acc38cb","slug":"prognosis","fullItemName":"Prognosis"},{"id":"48fb1bb9-46aa-5515-a112-656b86a86a56","slug":"complications","fullItemName":"Complications"}]},{"id":"3916f955-e558-5e75-911e-ae48f8579e84","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c59566b4-f12c-545c-8941-a7de38155871","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"23eadfb4-a45e-50b5-9d14-0f785ac86a84","slug":"assessment","fullItemName":"Assessment"},{"id":"a1f19a88-0a61-5514-b729-f6ba8636d70e","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"aa038862-8424-552a-84d0-e962619a7e33","fullItemName":"Management","slug":"management","subChapters":[{"id":"a41dab9c-d988-5d7a-813e-2d7a1658f5bc","slug":"management-of-blepharitis","fullItemName":"Scenario: Management of blepharitis"}]},{"id":"e0741730-0deb-5ab5-9f8a-0113b66dbe06","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"48e19546-bded-5436-9f23-e37a6fc78e36","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b75f0439-fc4c-5236-954c-bfe59f6da9a5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b6a215d3-627d-577f-ba63-d0387c86ce0e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"78dfcd62-db19-57fc-8f1f-0a100d3e4268","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8e70896c-9149-59b5-b395-aa848fcd9ab2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4289ac7a-ea00-51b4-8b87-184e9a519291","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"28ab262f-aac6-5c78-badf-72aa21ca0119","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"aa038862-8424-552a-84d0-e962619a7e33","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"dc7fdc51-0a30-5b09-ac1b-b8d3f106c518","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 1d943bd3-f09e-4f57-998e-a90784bed4ad --><h3>How should I manage blepharitis?</h3><!-- end field 1d943bd3-f09e-4f57-998e-a90784bed4ad -->","summary":null,"htmlStringContent":"<!-- begin item 7e243487-d2f6-4f81-85e4-c37af921d452 --><!-- begin field 04aa032b-2776-4880-82eb-34c813dcb137 --><ul><li><strong>If <a class=\"topic-reference internal-reference\" href=\"/topics/blepharitis/management/management-of-blepharitis/#referral\">referral</a> is not indicated, advise the person that:</strong><ul><li>Blepharitis is a chronic, intermittent condition which requires ongoing maintenance treatment — cure is generally not possible.<ul><li>Patient information is available from the NHS ‘<a data-hyperlink-id=\"a696acbb-45c7-4f34-bc73-aa460095d033\" href=\"https://www.nhs.uk/conditions/blepharitis/\" target=\"_blank\">Blepharitis</a>’ and Association of Optometrists ‘<a data-hyperlink-id=\"5b6fb6ef-deb2-47f7-a1ee-aa460095d050\" href=\"https://www.aop.org.uk/advice-and-support/for-patients/eye-conditions/blepharitis\" target=\"_blank\">Blepharitis</a>’.</li></ul></li><li>Symptoms can usually be controlled with self-care measures such eyelid hygiene and warm compresses.<ul><li>The eyelid can be cleansed by wetting a cloth or cotton bud with cleanser (for example, baby shampoo diluted 1:10 with warm water) and gently wiping along the lid margins to clear any lid debris.</li><li>Eyelids should be cleaned twice daily initially, then once daily as symptoms improve.</li><li>In addition, a warm compress (a clean cloth warmed with hot water) should be applied to closed eyelids for 5–10 minutes once or twice daily — compresses should not be too hot as this may burn the skin.</li><li>Eyelid hygiene should be continued even when symptoms are well controlled to minimise number and severity of relapses.</li></ul></li><li>For posterior blepharitis, a brief gentle eyelid massage following the use of a warm compress can help improve expression of Meibomian gland secretions.<ul><li>Care must be taken to prevent mechanical irritation.</li><li>Pressure on the eye area should be avoided in people with glaucoma.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/meibomian-cyst-chalazion/\">Meibomian cyst (chalazion)</a>.</li></ul></li><li>Eye make-up (especially eyeliner and mascara) should be avoided.</li><li>They should seek review if symptoms persist, worsen or new features develop.</li></ul></li><li><strong>If there is evidence of an associated condition (such as dry eye syndrome, seborrhoeic dermatitis or rosacea) ensure this is appropriately treated:</strong><ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/dry-eye-syndrome/\">Dry eye syndrome</a>, <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/rosacea/\">Rosacea - acne</a>.</li></ul></li><li><strong>If eyelid measures are ineffective:</strong><ul><li>Review the diagnosis and consider the need for <a class=\"topic-reference internal-reference\" href=\"/topics/blepharitis/management/management-of-blepharitis/#referral\">referral</a>.</li><li>Do not prescribe topical steroids.</li><li>For anterior blepharitis, consider prescribing a topical antibiotic (such as chloramphenicol) to be rubbed into the lid margin.<ul><li>The frequency and duration of topical antibiotic treatment depends on the severity of the blepharitis and response.</li><li>For prescribing information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/conjunctivitis-infective/\">Conjunctivitis - infective</a>.</li></ul></li><li>For posterior blepharitis associated with meibomian gland dysfunction and rosacea consider prescribing oral antibiotics (such as doxycycline [off-label] or tetracycline [contraindicated in pregnancy, lactation and in children under 12 years]).<ul><li>For information on prescribing, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rosacea/\">Rosacea - acne</a>.</li></ul></li></ul></li></ul><!-- end field 04aa032b-2776-4880-82eb-34c813dcb137 --><!-- end item 7e243487-d2f6-4f81-85e4-c37af921d452 -->","subChapters":[{"id":"9a1c95e3-2214-5899-9bd9-87173fe595f7","slug":"basis-for-recommendation-64b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field aee41c00-b1d5-4e5a-aa71-48b6f6b19d2b --><h4>Basis for recommendation</h4><!-- end field aee41c00-b1d5-4e5a-aa71-48b6f6b19d2b -->","summary":null,"htmlStringContent":"<!-- begin item 64bb89be-106d-47f6-9c2c-b9eed9fee37c --><!-- begin field 3e21eea2-cb26-491f-923a-4da39672e88d --><p>The recommendations on management of blepharitis are based on the clinical guidelines <em>Blepharitis – Preferred Practice Pattern 2018 </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>] and <em>Blepharitis (lid margin disease)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>], a Cochrane review <em>Interventions for blepharitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Lindsley, 2012</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Benitez-Del-Castillo, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Carlisle, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Duncan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>].</p><h5>Advice</h5><ul><li>Expert opinion in a clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>] and review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>] highlight the importance of patient education on the chronic nature of blepharitis and the need for compliance with ongoing treatment (in particular eyelid hygiene) even when blepharitis is well controlled.</li><li>Advice on avoidance of cosmetics (especially eyeliner and mascara) is based on clinical guidance from the College of Optometrists [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>].</li></ul><h5>Eyelid hygiene and warm compresses</h5><ul><li>Expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Duncan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>] is that eyelid hygiene is the mainstay of treatment of blepharitis.</li><li>Lid cleansing removes bacteria and deposits from lid margins and improves symptoms in most people with blepharitis. High quality evidence on the comparative efficacy of different lid hygiene regimes is lacking [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>].<ul><li>Eyelid cleansing is particularly useful for anterior blepharitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li><li>The optimal dilution factor of baby shampoo with water is unknown, but 1:10 is often recommended as providing a good balance between irritating and cleaning actions.</li></ul></li><li>Warm compresses soften adherent scale or discharge and warm meibomian secretions to aid gland expression [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>].<ul><li>Warm compresses, in addition to eyelid cleansing with lid massage, may be particularly helpful in management of posterior blepharitis and meibomian gland dysfunction (MDG) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li><li>Expression of the meibomian glands through lid massage must be performed with care — manipulation of the eyelid can cause mechanically induced irritation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li><li>People with glaucoma should be advised to avoid putting pressure on the lids as this may subsequently increase eye pressure [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li></ul></li></ul><h5>Optimal management of associated conditions</h5><ul><li>Blepharitis is associated with a number of other conditions (such as dry eye syndrome, seborrhoeic dermatitis and rosacea) which may share common aetiologies and predisposing factors. Recognition and appropriate treatment of underlying conditions is recommended in clinical guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>] and a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>].</li></ul><h5>Topical corticosteroids</h5><ul><li>A Cochrane review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Lindsley, 2012</a>] looking at interventions for chronic blepharitis found that evidence of effectiveness of topical steroids was inconclusive. In addition, corticosteroids may have significant adverse effects and should only be initiated by an ophthalmologist in secondary care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">British Oculoplastic Surgery Society, 2014</a>].</li></ul><h5>Topical antibiotics</h5><ul><li>The recommendation that topical antibiotics can be considered as second line treatment in people with anterior blepharitis if lid measures have failed is based on expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Carlisle, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Duncan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>]. The recommendation on use of chloramphenicol is taken from clinical guidance from the College of Optometrists [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>].</li><li>A Cochrane review (n=34 studies [26 randomised controlled trials and 8 quasi‐randomized controlled trials]) including 2169 people with blepharitis (1661 with anterior or mixed blepharitis and 508 with posterior blepharitis) found that [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Lindsley, 2012</a>]:<ul><li>Topical antibiotics provided some symptomatic relief and were effective in eradicating bacteria from the eyelid margin for anterior blepharitis — there was no difference between the types of topical antibiotics used.</li><li>Lid hygiene may provide symptomatic relief for anterior and posterior blepharitis.</li></ul></li><li>Clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>] do not give a specific timescale for use of topical antibiotics and recommend that frequency and duration of treatment is guided by the severity of blepharitis and response to treatment<ul><li>A review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>] states that topical antibiotics are commonly continued for 4-8 weeks depending on severity.</li></ul></li></ul><h5>Oral antibiotics</h5><ul><li>The recommendation that oral antibiotics can be considered as second line treatment in people with posterior blepharitis and meibomian gland dysfunction if lid hygiene measures have failed is based on expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Carlisle, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Duncan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Putnam, 2016</a>]. Evidence on the effectiveness of oral antibiotics for blepharitis has been shown to be inconclusive.</li><li>A Cochrane review (n=34 studies [26 randomised controlled trials and 8 quasi‐randomized controlled trials]) including 2169 people with blepharitis (1661 people with anterior or mixed blepharitis and 508 with posterior blepharitis) found that [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Lindsley, 2012</a>]:<ul><li>Evidence for the effectiveness of oral antibiotics was inconclusive.</li><li>Lid hygiene may provide symptomatic relief for anterior and posterior blepharitis.</li></ul></li><li>The recommendation by the American Association of Ophthalmology on use of oral antibiotics in people with MGD if eyelid cleansing/meibomian gland expression has failed is based in part on small clinical trials which found that oral tetracyclines improved symptoms in people with rosacea and MGD [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li></ul><!-- end field 3e21eea2-cb26-491f-923a-4da39672e88d --><!-- end item 64bb89be-106d-47f6-9c2c-b9eed9fee37c -->","subChapters":[]}]},{"id":"ccdd131e-a55a-5c30-a824-5c5a8df31351","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field 6881181d-6398-4aa6-ac23-bb4dee16de2e --><h3>When should I refer a person with blepharitis?</h3><!-- end field 6881181d-6398-4aa6-ac23-bb4dee16de2e -->","summary":null,"htmlStringContent":"<!-- begin item 0fbd95e9-59ec-4201-8db7-7bdeff1d0252 --><!-- begin field c7784419-ee2d-4e4d-90e7-a385c66f3368 --><ul><li><strong>Refer for same-day ophthalmological assessment if:</strong><ul><li>There are symptoms of corneal disease (such as pain and blurred vision).</li><li>The person has experienced rapid onset visual loss.</li><li>Orbital or pre-septal cellulitis is suspected, or</li><li>An eye becomes painful and/or red — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/red-eye/\">Red eye</a>.</li></ul></li><li><strong>Refer to ophthalmology (with urgency depending on the clinical situation) if:</strong><ul><li>There is eyelid asymmetry or deformity (to exclude malignancy).</li><li>There is a gradual deterioration of vision.</li><li>An underlying condition (such as Sjögren's syndrome or ocular pemphigoid) is suspected.</li><li>Treatment in primary care has failed — have a low threshold for referring children.</li><li>The diagnosis is uncertain<strong>.</strong></li></ul></li></ul><!-- end field c7784419-ee2d-4e4d-90e7-a385c66f3368 --><!-- end item 0fbd95e9-59ec-4201-8db7-7bdeff1d0252 -->","subChapters":[{"id":"8b008e01-5e3b-5886-9344-e9ce0fe8ad6d","slug":"basis-for-recommendation-18b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ef4a4f1c-d708-4c76-a153-5d1579754442 --><h4>Basis for recommendation</h4><!-- end field ef4a4f1c-d708-4c76-a153-5d1579754442 -->","summary":null,"htmlStringContent":"<!-- begin item 18b5fa7e-1437-47dc-920a-32408f569e98 --><!-- begin field cbfffd04-3112-48f3-9ecf-b9e63991c03d --><p>The recommendations on when to refer a person with blepharitis are based on the clinical guidelines <em>Blepharitis – Preferred Practice Pattern 2018</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>] and Blepharitis (lid margin disease) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">College of Optometrists, 2018</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">Carlisle, 2015</a>].</p><ul><li>Malignancy (such as basal cell carcinoma, squamous cell carcinoma, melanoma, or sebaceous carcinoma) should be considered if blepharitis is unilateral or associated with loss of eyelashes, a nodular mass, ulceration, scarring, yellow conjunctival nodules, marked inflammation or is non-responsive to treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li><li>Autoimmune disease (such as ocular mucous membrane pemphigoid) may present with conjunctival scarring and deformity of the lids [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li><li>The recommendation on having a low threshold for referring children with blepharitis is based on guidance from the American Academy of Opthalmolgy guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>] which states that the risk of serious complications, although rare, is higher in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/blepharitis/references/\">American Academy of Ophthalmology, 2018</a>].</li></ul><!-- end field cbfffd04-3112-48f3-9ecf-b9e63991c03d --><!-- end item 18b5fa7e-1437-47dc-920a-32408f569e98 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}